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There have been few studies of the pharmacodynamics of nonsteroidal antiinflammatory 
drugs (NSAIDs) using PK–PD modelling, yet this approach offers the advantage of defining 
the whole concentration–effect relationship, as well as its time course and sensitivity. In this 
study, ketoprofen (KTP) was administered intravenously to goats as the racemate (3.0 mg/kg 
total dose) and as the single enantiomers, S(+) KTP and R(−) KTP (1.5 mg/kg of each). The 
pharmacokinetics and pharmacodynamics of KTP were investigated using a tissue cage 
model of acute inflammation. The pharmacokinetics of both KTP enantiomers was 
characterized by rapid clearance, short mean residence time (MRT) and low volume of 
distribution. The penetration of R(−) KTP into inflamed (exudate) and noninflamed 
(transudate) tissue cage fluids was delayed but area under the curve values were only slightly 
less than those in plasma, whereas MRT was much longer. The S(+) enantiomer of KTP 
penetrated less readily into exudate and transudate. Unidirectional inversion of R(−) to S(+) 
KTP occurred. Both rac-KTP and the separate enantiomers produced marked inhibition of 
serum thromboxane B2 (TxB2) synthesis (ex vivo) and moderate inhibition of exudate 
prostaglandin E2 (PGE2) synthesis (in vivo); pharmacodynamic variables for S(+) KTP were 
Emax (%) = 94 and 100; IC50 (μg/mL) = 0.0033 and 0.0030; N = 0.45 and 0.58, respectively, 
where Emax is the maximal effect, IC50 the plasma drug concentration producing 50% of 
Emax and N the slope of log concentration/effect relationship. The IC50 ratio, serum 
TxB2:exudate PGE2 was 1.10. Neither rac-KTP nor the individual enantiomers suppressed 
skin temperature rise at, or leucocyte infiltration into, the site of acute inflammation. These 
data illustrate for KTP shallow concentration–response relationships, probable nonselectivity 
of KTP for cyclooxygenase (COX)-1 and COX-2 inhibition and lack of measurable effect on 
components of inflammation. 
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